Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer

Although neoadjuvant radiochemotherapy (nRCTx) is an established oncological treatment in patients with advanced rectal cancer, little is known about its effects on the tumor microenvironment. Quantity and composition of tumor infiltrating lymphocytes (TILs) are known to influence patients' pro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Jarosch, Armin, Sommer, Ulrich, Bogner, Andreas, Reißfelder, Christoph, Weitz, Jürgen, Krause, Mechthild, Folprecht, Gunnar, Baretton, Gustavo B., Aust, Daniela E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749657/
https://ncbi.nlm.nih.gov/pubmed/29308324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1393133
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi